$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Fatty acid esters as bioactive compounds 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/225
출원번호 US-0376617 (1999-08-18)
우선권정보 GB0005440 (1996-03-15)
발명자 / 주소
  • Horrobin David Frederick,GBX
  • Manku Mehar,GBX
  • McMordie Austin,GBX
  • Knowles Philip,GBX
  • Redden Peter,GBX
  • Pitt Andrea,GBX
출원인 / 주소
  • Scotia Holdings PLC, GBX
대리인 / 주소
    Gray, Esq.
인용정보 피인용 횟수 : 92  인용 특허 : 1

초록

Compounds of structure (I), and when for use in therapy: where R.sub.1 is an acyl group derived from a C.sub.16-30 fatty acid with two or more cis or trans double bonds and particularly an n-6 or n-3 series EFA or conjugated linoleic acid, or columbinic acid, or parinaric acid and R.sub.2 is as R.su

대표청구항

[ What is claimed is:] [1.]1. A compound having the following structure re R.sub.1 is an acyl group derived from a C.sub.16-30 fatty acid with two or more cis or trans double bonds and R.sub.2 is a nutrient, drug or other bioactive residue as the active in the body and R.sub.3 is either hydrogen of

이 특허에 인용된 특허 (1)

  1. Horrobin David Frederick,GBX ; Manku Mehar,GBX ; McMordie Austin,GBX ; Knowles Philip,GBX ; Redden Peter,CAX ITX B4N 4H8 ; Pitt Andrea,GBX, Nicotinic acid esters and pharmaceutical compositions containing them.

이 특허를 인용한 특허 (92)

  1. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Conroy, Suzanne; Sunter, Brian; Henrich, Georgette, Application of a coating on a medical device.
  2. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Conroy, Suzanne; Sunter, Brian; Henrich, Georgette, Application of a coating on a medical device.
  3. Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; McNamara, Philip, Barrier layer.
  4. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Barrier layer with underlying medical device and one or more reinforcing support structures.
  5. Jackowski, George; MacSweeney, Rachelle; Shaikh, Nisar; Yantha, Jason; Schini-Kerth, Valerie, Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events.
  6. Martakos, Paul; Herweck, Steve A.; Prowse, Jocelyn; Horton, Anthony Richard; Faucher, Keith M.; Ferraro, Joseph, Coated surgical mesh.
  7. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph F.; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Coating material and medical device system including same.
  8. Nerenberg,Arnold P., Composition for mitigating a pernicious thrombotic event.
  9. Hustvedt, Svein Olaf; Olesen, Preben Houlberg; Berge, Gunnar; Mullertz, Anette, Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof.
  10. Hustvedt, Svein Olaf; Olesen, Preben Houlberg; Berge, Gunnar; Müllertz, Anette, Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof.
  11. Fraser, David A; Garras, Alexis, Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof.
  12. Changaris,David G., Conjugated fatty acid based emulsion and methods for preparing and using same.
  13. Galvez,Juan Miguel Garro; Angers,Paul; Briand,Sandie, Conjugated linolenic acids and methods of preparation and purification and uses thereof.
  14. Faucher, Keith M.; Tang, Hui; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
  15. Faucher, Keith M.; Tang, Hui; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore; Sullivan, Allison; Melville, Greg; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
  16. Faucher, Keith M.; Tang, Hui; Martakos, Paul; Karwoski, Theodore; Sullivan, Allison; Melville, Greg; Corbeil, Scott E., Cross-linked fatty acid-based biomaterials.
  17. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith M.; Swanick, Thomas M., Cured gel and method of making.
  18. Faucher, Keith M.; Conroy, Suzanne; Albergo, Theresa K.; Bienkiewicz, Joseph, Cured oil-hydrogel biomaterial compositions for controlled drug delivery.
  19. Shashoua,Victor E.; Swindell,Charles E.; Webb,Nigel L.; Bradley,Matthews O., DHA-pharmaceutical agent conjugates of taxanes.
  20. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Drug delivery coating for use with a stent.
  21. Labrecque, Roger; Moodie, Geoffrey; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A., Drug delivery coating for use with a stent.
  22. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Smith, Jesse J., Fatty acid acetylated salicylates and their uses.
  23. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Smith, Jesse J., Fatty acid acetylated salicylates and their uses.
  24. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Smith, Jesse J., Fatty acid acetylated salicylates and their uses.
  25. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Smith, Jesse J., Fatty acid acetylated salicylates and their uses.
  26. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Smith, Jesse J., Fatty acid acetylated salicylates and their uses.
  27. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Smith, Jesse J., Fatty acid acetylated salicylates and their uses.
  28. Vu, Chi B.; Bemis, Jean E.; Jirousek, Michael R.; Milne, Jill C.; Smith, Jesse J., Fatty acid acylated salicylates and their uses.
  29. Vu, Chi B.; Bemis, Jean E.; Jirousek, Michael R.; Milne, Jill C.; Smith, Jesse J., Fatty acid acylated salicylates and their uses.
  30. Vu, Chi B.; Bemis, Jean E.; Jirousek, Michael R.; Milne, Jill C.; Smith, Jesse J., Fatty acid acylated salicylates and their uses.
  31. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Vu, Chi B., Fatty acid niacin conjugates and their uses.
  32. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Vu, Chi B., Fatty acid niacin conjugates and their uses.
  33. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Vu, Chi B., Fatty acid niacin conjugates and their uses.
  34. Webb,Nigel L.; Bradley,Matthews O.; Anthony,Forrest; Fisher,Mark, Fatty acid-anticancer conjugates and uses thereof.
  35. Webb, Nigel L.; Bradley, Matthews O.; Swindell, Charles S.; Shashoua, Victor E., Fatty acid-pharmaceutical agent conjugates.
  36. Swindell, Charles S.; Fegley, Glenn J., Fatty alcohol drug conjugates.
  37. Swindell, Charles S.; Fegley, Glenn J., Fatty amine drug conjugates.
  38. Swanick, Thomas M.; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul, Fatty-acid based particles.
  39. Baes, Erik Karel; Wold, Ida Marie, Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof.
  40. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith M.; Swanick, Thomas M., Heat cured gel and method of making.
  41. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
  42. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steve A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
  43. Faucher, Keith M.; Tang, Hui; Rogers, Lisa; Ferraro, Joseph; Martakos, Paul; Herweck, Steven A.; Karwoski, Theodore, Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings.
  44. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Implantable barrier device.
  45. Dhondt, Maria; De Scheerder, Ivan; Jacobs, Pierre; Martens, Johan, Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent.
  46. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Vu, Chi B., Lipoic acid acylated salicylate derivatives and their uses.
  47. Corbeil, Scott E.; Labrecque, Roger; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Conroy, Suzanne; Sunter, Brian; Bromander, Edward; Henrich, Georgette, Method and apparatus for application of a fresh coating on a medical device.
  48. Jackowski, George; Macsweeney, Rachelle; Shaikh, Nisar; Yantha, Jason; Schini-Kerth, Valerie, Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics.
  49. Webb, Nigel L.; Bradley, Matthews O.; Swindell, Charles S.; Shashoua, Victor E., Method of treating a liver disorder with fatty acid-antiviral agent conjugates.
  50. Cossu, Giulio; Clementi, Emilio; Brunelli, Silvia, Method of treatment for muscular dystrophy.
  51. Changaris, David G.; Sullivan, Kelly, Methods and composition for suppression of deep seated fungal growth on skin.
  52. Changaris, David G.; Sullivan, Kelly, Methods and composition for suppression of deep seated fungal growth on skin.
  53. Bobotas, George; Fawzy, Abdel Aziz, Methods of administering compositions comprising docosapentaenoic acid.
  54. Anders, Marion W.; Robotham, James L.; Sheu, Shey-Shing; Brookes, Paul Spencer; Shojaie, Jalil; Olson, Leif; Parton, Richard L., Mitochondria-targeted antioxidant prodrugs and methods of use.
  55. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  56. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  57. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  58. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  59. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  60. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  61. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  62. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  63. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  64. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  65. Bernick, Brian A.; Persicaner, Peter H. R.; Amadio, Julia M., Natural combination hormone replacement formulations and therapies.
  66. Milne, Jill C.; Jirousek, Michael R.; Bemis, Jean E.; Vu, Chi B., Niacin conjugated fatty acid mixtures and their uses.
  67. Miller, Raymond A., Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline.
  68. Jackowski, George; MacSweeney, Rachelle; Shaikh, Nisar; Yantha, Jason; Schini-Kerth, Valerie, Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels.
  69. Bobotas, George; Fawzy, Abdel Aziz, Omega-3 pentaenoic acid compositions and methods of use.
  70. Herweck, Steve A.; Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Faucher, Keith M.; McNamara, Philip; Labrecque, Roger; Conroy, Suzanne; Carlton, Trevor, Perforated bioabsorbable oil film and methods for making the same.
  71. Herweck, Steve A.; Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Faucher, Keith M.; McNamara, Philip; Labrecque, Roger; Conroy, Suzanne; Carlton, Trevor, Perforated fatty acid films.
  72. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D., Progesterone formulations.
  73. King,Howard Gregg; Shigeura,John; Nordman,Eric S.; Desmond,Sean Matthew, Sample handling system for a multi-channel capillary electrophoresis device.
  74. Carpenter, Jr., Alan P., Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent.
  75. Barrett, Karen Elizabeth; Green, Martin Richard; Hu, Heng-Long; Parmar, Preyesh; Powell, Jonathan Richard; Rawlings, Anthony Vincent, Skin care composition containing conjugated linoleic acid and a phenolic compound.
  76. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Irani, Neda; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D., Soluble estradiol capsule for vaginal insertion.
  77. Swanick, Thomas M.; Ferraro, Joseph; Martakos, Paul; Rogers, Lisa; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; McNamara, Philip, Stand-alone film and methods for making the same.
  78. Jackowski, George; MacSweeney, Rachelle; Shaikh, Nisar; Yantha, Jason; Schini-Kerth, Valerie, Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels.
  79. Shadiack, Annette; Persicaner, Peter H. R.; Inskeep, Philip B.; Thorsteinsson, Thorsteinn; Sancilio, Frederick D.; Legassie, Jason D., Steroid hormone pharmaceutical composition.
  80. Smith,William; Kuklev,Dmitry V., Synthesis of polyconjugated fatty acids.
  81. Herweck, Steve A.; Ferraro, Joseph; Martakos, Paul; Karwoski, Theodore; Horton, Anthony Richard, Tissue separating device with reinforced support for anchoring mechanisms.
  82. Swanick, Thomas M.; Bienkiewicz, Joe; Ferraro, Joseph; Martakos, Paul; Faucher, Keith M.; Dale, Alicia, Tissue-separating fatty acid adhesion barrier.
  83. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Irani, Neda; Sancilio, Frederick D., Transdermal hormone replacement therapies.
  84. Troyer, Ellen M.; Thornton, Spencer P.; Whiting, K. Steven; Kaufman, Richard, Treatment of dry eye syndrome.
  85. Labrecque, Roger; McNamara, Philip; Ferraro, Joseph; Rogers, Lisa; Martakos, Paul; Karwoski, Theodore; Herweck, Steve A.; Faucher, Keith; Swanick, Thomas M., UV cured gel and method of making.
  86. Domingo Pedrol, Joan Carles; Villegas Garcia, Jose Antonio, Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage.
  87. Domingo Pedrol, Joan Carles; Villegas Garcia, Jose Antonio, Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage.
  88. Shibuya, Hajime, Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events.
  89. Shibuya, Hajime, Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events.
  90. Shibuya, Hajime, Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events.
  91. Bernick, Brian A.; Amadio, Julia M., Vaginal inserted estradiol pharmaceutical compositions and methods.
  92. Mirkin, Sebastian; Amadio, Julia M.; Bernick, Brian A., Vaginal inserted estradiol pharmaceutical compositions and methods.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로